Deadline Determined For Proposal of Case Management in Xarelto Lawsuit Groups

March 23, 2016 – – BloodThinnerHelp.com reports on the recent deadline decision regarding a Case Management Order for the bellwether trials involving Xarelto. In Case Management Order No. 3, Judge Eldon Fallon, who will be presiding over the bellwether trials, announced that in order to select cases for trials, “The parties are to meet and confer before June 10, 2016 to propose a Case Management Order to address the selection method for bellwether plaintiff cases for trial. The parties will submit the proposed Case Management Order to the Court by July 1, 2016.”

Plaintiffs first began filing cases against the manufacturers, Johnson & Johnson and Bayer AG, after alleging that the drug caused life-threatening side effects about which the companies did not adequately warn them. The drug was issued two “black box warnings” by the FDA to inform consumers that patients who prematurely discontinued Xarelto were at a higher risk of blood clots, deep vein thrombosis, and epidural/spinal hematoma. Another warning told patients that “placement or removal of an epidural catheter or lumbar puncture is best performed when the anticoagulant effect of rivaroxaban is low; however, the exact timing to reach a sufficiently low anticoagulant effect in each patient is not known.”

Side effects reported by patients who used Xarelto include stroke, heart attack, pulmonary embolism, internal bleeding, gastrointestinal bleeding, rectal bleeding, epidural hematoma and brain hemorrhages. Federally, the multidistrict litigation panel in Eastern Louisiana that was created to better manage the large volume of cases has accumulated close to 3,000 lawsuits all alleging similar issues with the drug.

As more cases are expected to be brought to court, Attorney Joseph Osborne is working to ensure that those who have taken Xarelto and believe they have suffered negative side effects as a result of the drug have the opportunity to explore their legal rights. Qualifying individuals may be entitled to legal action and financial compensation. Osborne is currently offering complimentary legal consultations to affected parties.

For more information, or to ask questions about Xarelto, contact Joseph Osborne, Esq. by calling (866) 425-8902.

###

Contact BloodThinnerHelp.com:

Joseph Osborne
866-425-8902
Mizner Park
433 Plaza Real Blvd., Ste. 271
Boca Raton, FL 33432

ReleaseID: 60008821